Drugs that contain Lapatinib Ditosylate

1. Tykerb patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8821927 NOVARTIS Pharmaceutical composition
Sep, 2029

(5 years from now)

Market Authorisation Date: 13 March, 2007

Treatment: NA


How can I launch a generic of TYKERB before it's drug patent expiration?
More Information on Dosage

TYKERB family patents

Family Patents